Ordensklinikum Linz

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Follicular lymphoma1 trial
• High blood pressure1 trial
• Hypertrophic cardiomyopathy1 trial
• Liver and biliary tract cancer1 trial
• Metastatic breast cancer1 trial
• Multiple myeloma1 trial
• Obstructive sleep apnoea1 trial
• Pancreatic cancer1 trial
• Pulmonary arterial hypertension1 trial

Phase

• Phase 33 trials

Status

• Recruiting3 trials
• Not yet recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Medical University of Graz3 trials
• AOP Orphan Pharmaceuticals AG1 trial
• Eli Lilly and Company1 trial
• Inspire Medical Systems, Inc.1 trial
• Regeneron Pharmaceuticals1 trial
• and 1 more

Running trials

• Recruiting

  SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors

  NCT07341321· Medical University of Graz· Source

  Contact: Stephanie Hametner-Schreil

• Recruiting

  EURO-STIM Registry

  NCT06971796· Inspire Medical Systems, Inc.· Source

  Contact: Magdalena Sturm

• Enrolling by invitation

  A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients

  NCT06445673· AOP Orphan Pharmaceuticals AG· Source

• Recruiting

  Austrian Hypertrophic Cardiomyopathy Registry

  NCT06368518· Medical University of Graz· Source

  Contact: Christian Ebner, MD

• Recruiting

  A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  NCT06091254· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

  NCT05526443· Medical University of Graz· Source

  Contact: Holger Rumpold, PD MD

• Active, not recruiting

  A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

  NCT02246621· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Follicular lymphoma1 recruiting
• High blood pressure1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Liver and biliary tract cancer1 recruiting
• Obstructive sleep apnoea1 recruiting
• Pancreatic cancer1 recruiting
• Pulmonary arterial hypertension1 recruiting

Closed trials

• Completed

  Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

  NCT05804032· Phase 3· University of Heidelberg Medical Center· Source